Back to Market Feed

Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2956 per EA under NDC 68462065301. Its NADAC has been published 64 times since Jul 16, 2025.

FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

68462065301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210754

FDA Approved

7/5/2022

TE Code

AB

On Market Since

5/12/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 64 times since Jul 16, 2025, and over the history we have for it it has declined 12.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2956 per EA
All-time high$0.3373 (Jul 16, 2025)
All-time low$0.2956 (Sep 23, 2026)
52-week high$0.3153
52-week low$0.2956
Median price$0.3104
Average price$0.3111
Largest weekly change-4.7% (Sep 17, 2025)
Weeks tracked64
Tracking sinceJul 16, 2025

Price History

1W

0.0%

1M

-2.5%

3M

-3.0%

6M

-5.8%

1Y

-4.5%

3Y

N/A

5Y

N/A

All

-12.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0622
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0622
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0648
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0648
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0648
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0648
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0648
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Glenmark Pharmaceuticals Inc., USA manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Central Nervous System Stimulant class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2956 per EA (NDC 68462065301), effective Sep 30, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 12.4%. It has been tracked across 64 weekly CMS publications since Jul 16, 2025.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Jul 16, 2025, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2956 (Sep 23, 2026) to a high of $0.3373 (Jul 16, 2025), with a median of $0.3104 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 68462065301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.